Software - Application
Compare Stocks
5 / 10Stock Comparison
FRGE vs MS vs GS vs ICE vs CME
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Capital Markets
Financial - Capital Markets
Financial - Data & Stock Exchanges
Financial - Data & Stock Exchanges
FRGE vs MS vs GS vs ICE vs CME — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Financial - Capital Markets | Financial - Capital Markets | Financial - Data & Stock Exchanges | Financial - Data & Stock Exchanges |
| Market Cap | $549M | $302.59B | $287.62B | $88.45B | $104.07B |
| Revenue (TTM) | $93M | $103.14B | $126.85B | $12.64B | $6.52B |
| Net Income (TTM) | $-63M | $16.18B | $16.67B | $3.30B | $4.24B |
| Gross Margin | 11.9% | 55.6% | 41.1% | 61.9% | 86.1% |
| Operating Margin | -73.5% | 17.1% | 14.5% | 38.7% | 64.9% |
| Forward P/E | — | 16.0x | 15.6x | 19.5x | 23.5x |
| Total Debt | $15M | $360.49B | $616.93B | $20.28B | $3.76B |
| Cash & Equiv. | $105M | $75.74B | $182.09B | $837M | $4.42B |
FRGE vs MS vs GS vs ICE vs CME — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Feb 21 | Mar 26 | Return |
|---|---|---|---|
| Forge Global Holdin… (FRGE) | 100 | 29.2 | -70.8% |
| Morgan Stanley (MS) | 100 | 216.6 | +116.6% |
| The Goldman Sachs G… (GS) | 100 | 269.1 | +169.1% |
| Intercontinental Ex… (ICE) | 100 | 148.8 | +48.8% |
| CME Group Inc. (CME) | 100 | 160.0 | +60.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FRGE vs MS vs GS vs ICE vs CME
Each card shows where this stock fits in a portfolio — not just who wins on paper.
FRGE is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.37, Low D/E 6.4%, current ratio 4.74x
- +235.6% vs ICE's -10.4%
MS is the clearest fit if your priority is long-term compounding and bank quality.
- 7.3% 10Y total return vs GS's 5.3%
- NIM 0.7% vs GS's 0.5%
GS has the current edge in this matchup, primarily because of its strength in growth exposure and valuation efficiency.
- Rev growth 17.0%, EPS growth 77.3%
- PEG 1.12 vs ICE's 2.19
- 17.0% NII/revenue growth vs CME's 6.4%
- Lower P/E (15.6x vs 23.5x), PEG 1.12 vs 1.71
ICE is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 14 yrs, beta 0.33, yield 1.2%
- Beta 0.33, yield 1.2%, current ratio 1.02x
- Beta 0.33 vs GS's 1.47, lower leverage
- 2.3% ROA vs FRGE's -24.9%, ROIC 7.5% vs -45.6%
CME ranks third and is worth considering specifically for quality and dividends.
- 62.0% margin vs FRGE's -67.4%
- 3.8% yield, 6-year raise streak, vs ICE's 1.2%, (1 stock pays no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 17.0% NII/revenue growth vs CME's 6.4% | |
| Value | Lower P/E (15.6x vs 23.5x), PEG 1.12 vs 1.71 | |
| Quality / Margins | 62.0% margin vs FRGE's -67.4% | |
| Stability / Safety | Beta 0.33 vs GS's 1.47, lower leverage | |
| Dividends | 3.8% yield, 6-year raise streak, vs ICE's 1.2%, (1 stock pays no dividend) | |
| Momentum (1Y) | +235.6% vs ICE's -10.4% | |
| Efficiency (ROA) | 2.3% ROA vs FRGE's -24.9%, ROIC 7.5% vs -45.6% |
FRGE vs MS vs GS vs ICE vs CME — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FRGE vs MS vs GS vs ICE vs CME — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CME leads in 2 of 6 categories
GS leads 2 • FRGE leads 0 • MS leads 0 • ICE leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CME leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
GS is the larger business by revenue, generating $126.9B annually — 1365.7x FRGE's $93M. CME is the more profitable business, keeping 62.0% of every revenue dollar as net income compared to FRGE's -67.4%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $93M | $103.1B | $126.9B | $12.6B | $6.5B |
| EBITDAEarnings before interest/tax | -$64M | $26.3B | $23.4B | $6.5B | $4.7B |
| Net IncomeAfter-tax profit | -$63M | $16.2B | $16.7B | $3.3B | $4.2B |
| Free Cash FlowCash after capex | -$40M | -$6.7B | $15.8B | $4.3B | $4.4B |
| Gross MarginGross profit ÷ Revenue | +11.9% | +55.6% | +41.1% | +61.9% | +86.1% |
| Operating MarginEBIT ÷ Revenue | -73.5% | +17.1% | +14.5% | +38.7% | +64.9% |
| Net MarginNet income ÷ Revenue | -67.4% | +13.0% | +11.3% | +26.1% | +62.0% |
| FCF MarginFCF ÷ Revenue | -43.4% | -2.0% | -12.1% | +33.9% | +64.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +10.6% | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +8.1% | +48.9% | +45.8% | +23.1% | +21.4% |
Valuation Metrics
GS leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 22.8x trailing earnings, GS trades at a 16% valuation discount to ICE's 27.1x P/E. Adjusting for growth (PEG ratio), GS offers better value at 1.63x vs ICE's 3.05x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $549M | $302.6B | $287.6B | $88.4B | $104.1B |
| Enterprise ValueMkt cap + debt − cash | $459M | $587.3B | $722.5B | $107.9B | $103.4B |
| Trailing P/EPrice ÷ TTM EPS | -8.29x | 23.92x | 22.84x | 27.06x | 25.70x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 16.01x | 15.64x | 19.48x | 23.49x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.69x | 1.63x | 3.05x | 1.87x |
| EV / EBITDAEnterprise value multiple | — | 25.81x | 34.75x | 16.71x | 22.96x |
| Price / SalesMarket cap ÷ Revenue | 6.93x | 2.93x | 2.27x | 7.00x | 15.96x |
| Price / BookPrice ÷ Book value/share | 2.42x | 2.91x | 2.53x | 3.08x | 3.60x |
| Price / FCFMarket cap ÷ FCF | — | — | — | 20.62x | 24.82x |
Profitability & Efficiency
CME leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
CME delivers a 15.3% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $-29 for FRGE. FRGE carries lower financial leverage with a 0.06x debt-to-equity ratio, signaling a more conservative balance sheet compared to GS's 5.06x. On the Piotroski fundamental quality scale (0–9), ICE scores 9/9 vs FRGE's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -29.3% | +14.6% | +12.6% | +11.6% | +15.3% |
| ROA (TTM)Return on assets | -24.9% | +1.2% | +0.9% | +2.3% | +2.2% |
| ROICReturn on invested capital | -45.6% | +2.9% | +1.9% | +7.5% | +10.2% |
| ROCEReturn on capital employed | -31.3% | +3.8% | +3.6% | +9.5% | +3.6% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 5 | 4 | 9 | 5 |
| Debt / EquityFinancial leverage | 0.06x | 3.42x | 5.06x | 0.70x | 0.13x |
| Net DebtTotal debt minus cash | -$91M | $284.7B | $434.8B | $19.4B | -$666M |
| Cash & Equiv.Liquid assets | $105M | $75.7B | $182.1B | $837M | $4.4B |
| Total DebtShort + long-term debt | $15M | $360.5B | $616.9B | $20.3B | $3.8B |
| Interest CoverageEBIT ÷ Interest expense | — | 0.44x | 0.31x | 6.53x | 41.55x |
Total Returns (Dividends Reinvested)
GS leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GS five years ago would be worth $26,440 today (with dividends reinvested), compared to $3,052 for FRGE. Over the past 12 months, FRGE leads with a +235.6% total return vs ICE's -10.4%. The 3-year compound annual growth rate (CAGR) favors GS at 43.5% vs ICE's 14.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +1.2% | +5.7% | +1.8% | -2.1% | +9.1% |
| 1-Year ReturnPast 12 months | +235.6% | +63.0% | +70.6% | -10.4% | +4.6% |
| 3-Year ReturnCumulative with dividends | +101.3% | +138.4% | +195.2% | +50.8% | +71.4% |
| 5-Year ReturnCumulative with dividends | -69.5% | +136.2% | +164.4% | +43.4% | +64.5% |
| 10-Year ReturnCumulative with dividends | -70.9% | +732.3% | +534.3% | +225.3% | +284.9% |
| CAGR (3Y)Annualised 3-year return | +26.3% | +33.6% | +43.5% | +14.7% | +19.7% |
Risk & Volatility
Evenly matched — FRGE and CME each lead in 1 of 2 comparable metrics.
Risk & Volatility
CME is the less volatile stock with a -0.30 beta — it tends to amplify market swings less than GS's 1.47 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. FRGE currently trades 99.9% from its 52-week high vs ICE's 82.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.37x | 1.37x | 1.47x | 0.33x | -0.30x |
| 52-Week HighHighest price in past year | $45.03 | $194.83 | $984.70 | $189.35 | $329.16 |
| 52-Week LowLowest price in past year | $12.49 | $118.20 | $547.74 | $143.17 | $257.17 |
| % of 52W HighCurrent price vs 52-week peak | +99.9% | +97.6% | +94.0% | +82.5% | +87.1% |
| RSI (14)Momentum oscillator 0–100 | 71.0 | 66.0 | 59.5 | 38.8 | 44.1 |
| Avg Volume (50D)Average daily shares traded | 350K | 5.4M | 2.0M | 3.0M | 2.2M |
Analyst Outlook
Evenly matched — ICE and CME each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: FRGE as "Hold", MS as "Buy", GS as "Hold", ICE as "Buy", CME as "Hold". Consensus price targets imply 25.3% upside for ICE (target: $196) vs 0.0% for FRGE (target: $45). For income investors, CME offers the higher dividend yield at 3.81% vs ICE's 1.24%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | $45.00 | $205.75 | $995.89 | $195.71 | $320.25 |
| # AnalystsCovering analysts | 5 | 52 | 55 | 36 | 35 |
| Dividend YieldAnnual dividend ÷ price | — | +2.0% | +1.5% | +1.2% | +3.8% |
| Dividend StreakConsecutive years of raises | — | 11 | 12 | 14 | 6 |
| Dividend / ShareAnnual DPS | — | $3.81 | $13.48 | $1.93 | $10.92 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.4% | +3.5% | +1.6% | +0.3% |
CME leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). GS leads in 2 (Valuation Metrics, Total Returns). 2 tied.
FRGE vs MS vs GS vs ICE vs CME: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is FRGE or MS or GS or ICE or CME a better buy right now?
For growth investors, The Goldman Sachs Group, Inc.
(GS) is the stronger pick with 17. 0% revenue growth year-over-year, versus 6. 4% for CME Group Inc. (CME). The Goldman Sachs Group, Inc. (GS) offers the better valuation at 22. 8x trailing P/E (15. 6x forward), making it the more compelling value choice. Analysts rate Morgan Stanley (MS) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — FRGE or MS or GS or ICE or CME?
On trailing P/E, The Goldman Sachs Group, Inc.
(GS) is the cheapest at 22. 8x versus Intercontinental Exchange, Inc. at 27. 1x. On forward P/E, The Goldman Sachs Group, Inc. is actually cheaper at 15. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: The Goldman Sachs Group, Inc. wins at 1. 12x versus Intercontinental Exchange, Inc. 's 2. 19x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — FRGE or MS or GS or ICE or CME?
Over the past 5 years, The Goldman Sachs Group, Inc.
(GS) delivered a total return of +164. 4%, compared to -69. 5% for Forge Global Holdings, Inc. (FRGE). Over 10 years, the gap is even starker: MS returned +732. 3% versus FRGE's -70. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — FRGE or MS or GS or ICE or CME?
By beta (market sensitivity over 5 years), CME Group Inc.
(CME) is the lower-risk stock at -0. 30β versus The Goldman Sachs Group, Inc. 's 1. 47β — meaning GS is approximately -582% more volatile than CME relative to the S&P 500. On balance sheet safety, Forge Global Holdings, Inc. (FRGE) carries a lower debt/equity ratio of 6% versus 5% for The Goldman Sachs Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — FRGE or MS or GS or ICE or CME?
By revenue growth (latest reported year), The Goldman Sachs Group, Inc.
(GS) is pulling ahead at 17. 0% versus 6. 4% for CME Group Inc. (CME). On earnings-per-share growth, the picture is similar: The Goldman Sachs Group, Inc. grew EPS 77. 3% year-over-year, compared to 15. 4% for CME Group Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — FRGE or MS or GS or ICE or CME?
CME Group Inc.
(CME) is the more profitable company, earning 62. 0% net margin versus -83. 6% for Forge Global Holdings, Inc. — meaning it keeps 62. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CME leads at 64. 9% versus -103. 7% for FRGE. At the gross margin level — before operating expenses — CME leads at 86. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is FRGE or MS or GS or ICE or CME more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, The Goldman Sachs Group, Inc. (GS) is the more undervalued stock at a PEG of 1. 12x versus Intercontinental Exchange, Inc. 's 2. 19x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, The Goldman Sachs Group, Inc. (GS) trades at 15. 6x forward P/E versus 23. 5x for CME Group Inc. — 7. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ICE: 25. 3% to $195. 71.
08Which pays a better dividend — FRGE or MS or GS or ICE or CME?
In this comparison, CME (3.
8% yield), MS (2. 0% yield), GS (1. 5% yield), ICE (1. 2% yield) pay a dividend. FRGE does not pay a meaningful dividend and should not be held primarily for income.
09Is FRGE or MS or GS or ICE or CME better for a retirement portfolio?
For long-horizon retirement investors, CME Group Inc.
(CME) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 30), 3. 8% yield, +284. 9% 10Y return). Both have compounded well over 10 years (CME: +284. 9%, GS: +534. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between FRGE and MS and GS and ICE and CME?
These companies operate in different sectors (FRGE (Technology) and MS (Financial Services) and GS (Financial Services) and ICE (Financial Services) and CME (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: FRGE is a small-cap quality compounder stock; MS is a large-cap high-growth stock; GS is a large-cap high-growth stock; ICE is a mid-cap quality compounder stock; CME is a mid-cap income-oriented stock. MS, GS, ICE, CME pay a dividend while FRGE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.